Scientists have identified a molecular switch that may help explain how colorectal cancer becomes deadly. When levels of a ...

Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of ...

Predominantly third-line pancreatic cancer patients demonstrated durable survival despite advanced disease; patient who received Namodenoson as second-line therapy remains alive more than 18 months Ra ...

Unlike accidental cell death, some cells can actively decide to die through a controlled process. This is called programmed cell death and can occur in different forms, including apoptosis and ...

Researchers identified a six-gene signature in microscopic colorectal cancer (CRC) liver metastases that may help predict recurrence after treatment. The findings suggest these tiny, often ...

Researchers @hopkinskimmel and @HopkinsMed develop methods to predict which #livercancer patients do best with combination ...

In about 50% of people with colorectal cancer, tumour cells spread to distant organs. The ability of these metastases to grow into the liver tissue shapes prognosis. It emerges that liver fat promotes ...

Researchers found that a rare liver cancer evades immunotherapy by luring immune T cells away from the tumor and trapping them in nearby fibrous tissue. An FDA-approved drug called AMD3100 freed those ...

Stockholm - Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments in areas of high unmet medical need, announces today that it has received a Notice ...

Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to predict which patients with a primary ...

Sam Neill fought stage 3 angioimmunoblastic T-cell lymphoma, a rare type of blood cancer, but found success in treatment with ...